Kazia Therapeutics Ltd Stock Market Value
| KZIA Stock | USD 0.95 0.04 4.04% |
| Symbol | Kazia |
Kazia Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kazia Therapeutics. If investors know Kazia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kazia Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.39) | Revenue Per Share | Quarterly Revenue Growth 2.5 K | Return On Assets | Return On Equity |
The market value of Kazia Therapeutics is measured differently than its book value, which is the value of Kazia that is recorded on the company's balance sheet. Investors also form their own opinion of Kazia Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Kazia Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kazia Therapeutics' market value can be influenced by many factors that don't directly affect Kazia Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kazia Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kazia Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kazia Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kazia Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kazia Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kazia Therapeutics.
| 12/27/2024 |
| 03/27/2025 |
If you would invest 0.00 in Kazia Therapeutics on December 27, 2024 and sell it all today you would earn a total of 0.00 from holding Kazia Therapeutics Ltd or generate 0.0% return on investment in Kazia Therapeutics over 90 days. Kazia Therapeutics is related to or competes with CytomX Therapeutics, Assembly Biosciences, Ocular Therapeutix, Spero Therapeutics, Achilles Therapeutics, Sellas Life, and NLS Pharmaceutics. Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs More
Kazia Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kazia Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kazia Therapeutics Ltd upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 58.32 | |||
| Value At Risk | (16.00) | |||
| Potential Upside | 8.89 |
Kazia Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kazia Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kazia Therapeutics' standard deviation. In reality, there are many statistical measures that can use Kazia Therapeutics historical prices to predict the future Kazia Therapeutics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (1.03) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.36) |
Kazia Therapeutics Backtested Returns
Kazia Therapeutics has Sharpe Ratio of -0.12, which conveys that the firm had a -0.12 % return per unit of risk over the last 3 months. Kazia Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kazia Therapeutics' Standard Deviation of 10.48, risk adjusted performance of (0.07), and Mean Deviation of 5.98 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.86, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kazia Therapeutics will likely underperform. At this point, Kazia Therapeutics has a negative expected return of -1.31%. Please make sure to verify Kazia Therapeutics' accumulation distribution, as well as the relationship between the day median price and period momentum indicator , to decide if Kazia Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.34 |
Below average predictability
Kazia Therapeutics Ltd has below average predictability. Overlapping area represents the amount of predictability between Kazia Therapeutics time series from 27th of December 2024 to 10th of February 2025 and 10th of February 2025 to 27th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kazia Therapeutics price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Kazia Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Kazia Therapeutics lagged returns against current returns
Autocorrelation, which is Kazia Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kazia Therapeutics' stock expected returns. We can calculate the autocorrelation of Kazia Therapeutics returns to help us make a trade decision. For example, suppose you find that Kazia Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kazia Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kazia Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kazia Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kazia Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Kazia Therapeutics Lagged Returns
When evaluating Kazia Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kazia Therapeutics stock have on its future price. Kazia Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kazia Therapeutics autocorrelation shows the relationship between Kazia Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Kazia Therapeutics Ltd.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Kazia Therapeutics Correlation, Kazia Therapeutics Volatility and Kazia Therapeutics Alpha and Beta module to complement your research on Kazia Therapeutics. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Kazia Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.